Scarica l'app Stockscreener
1.44
7.06%
0.095
Precedente Chiudi:
$1.345
Aprire:
$1.34
Volume 24 ore:
52,288
Relative Volume:
0.45
Capitalizzazione di mercato:
$15.07M
Reddito:
$17.32M
Utile/perdita netta:
$-17.10M
Rapporto P/E:
-0.7296
EPS:
-1.9737
Flusso di cassa netto:
$-15.37M
1 W Prestazione:
+0.00%
1M Prestazione:
-13.77%
6M Prestazione:
-60.44%
1 anno Prestazione:
-57.14%
Intervallo 1D:
$1.30
$1.4558
Intervallo di 1 settimana:
$1.26
$1.4558
Portata 52W:
$1.26
$7.95
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Nome
Vivos Therapeutics Inc
Settore
Industria
Telefono
(866)908-4867
Indirizzo
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
1.44 | 14.08M | 17.32M | -17.10M | -15.37M | -1.9737 |
|
ABT
Abbott Laboratories
|
110.21 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
343.37 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.00 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.86 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.64 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Vivos Therapeutics Inc Borsa (VVOS) Ultime notizie
Winners Losers: Will Vivos Therapeutics Inc benefit from government policyWeekly Stock Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Bearish Setup: Is Vivos Therapeutics Inc part of any ETF2025 Technical Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - ACCESS Newswire
VVOS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Aug Sentiment: Can Vivos Therapeutics Inc maintain its current growth rateChart Signals & Low Drawdown Momentum Ideas - baoquankhu1.vn
Vivos Therapeutics (NASDAQ:VVOS) Stock Price Down 6.7% – Here’s What Happened - Defense World
CEO Moves: What are Complete Solaria Inc Equity Warrants recent SEC filings showingJuly 2025 Technicals & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
What dividend growth rate does Vivos Therapeutics Inc. offerProduct Launch & Low Drawdown Trading Strategies - mfd.ru
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST) - facilitiesmanagement-now.com
What are Vivos Therapeutics Inc.’s earnings expectationsIPO Watch & Free High Return Stock Watch Alerts - mfd.ru
Retail Surge: Can Vivos Therapeutics Inc maintain its current growth rate2025 Valuation Update & Real-Time Buy Signal Notifications - baoquankhu1.vn
Is Vivos Therapeutics Inc. showing insider buying2025 Price Targets & Verified Swing Trading Watchlists - mfd.ru
VIX Spike: How does Vivos Therapeutics Inc score in quality rankingsEarnings Growth Report & Expert Curated Trade Setups - baoquankhu1.vn
Will Vivos Therapeutics Inc. benefit from government policyDollar Strength & Weekly Top Stock Performers List - mfd.ru
Gap Down: Is Vivos Therapeutics Inc part of any ETF2025 Technical Overview & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Can Vivos Therapeutics Inc. stock hit record highs againJuly 2025 Analyst Calls & High Conviction Buy Zone Alerts - mfd.ru
Earnings Update: How correlated is Vivos Therapeutics Inc to the S P5002025 Macro Impact & Fast Moving Trade Plans - baoquankhu1.vn
Vivos Therapeutics Appoints Gregg Johnson to Board - TipRanks
Vivos Therapeutics Appoints Gregg C. E. Johnson to Board of Directors - TradingView
Vivos Therapeutics, Inc. Appoints Gregg C. E. Johnson as Independent Director of the Board and Compensation Committee of the Board, Effective February 4, 2026 - marketscreener.com
Vivos Therapeutics to Distribute SoundHealth’s FDA-Cleared Sonu and Spatial Sleep Bands - HIT Consultant
Buyout Rumor: Will Vivos Therapeutics Inc benefit from government policyJuly 2025 Final Week & Stock Market Timing Techniques - baoquankhu1.vn
Vivos Therapeutics and SoundHealth collaborate to expand access to groundbreaking FDA-cleared allergy and sleep technologies - marketscreener.com
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies - The Manila Times
Vivos Therapeutics Collaborates with SoundHealth to Enhance Airway and Sleep Health Solutions - Quiver Quantitative
Sound-based allergy and sleep bands join Vivos dentist network - Stock Titan
VIVOS Therapeutics, Inc. ($VVOS) Signs 12-Part Media Series with New to The Street - Eagle-Tribune
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Receives $4.92 Consensus PT from Brokerages - Defense World
Aug Catalysts: Is Vivos Therapeutics Inc showing insider buyingNew Guidance & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Income Plays: What is the PEG ratio of CHSCNMarket Risk Analysis & Reliable Price Breakout Alerts - baoquankhu1.vn
Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds - The Manila Times
Vivos Therapeutics Closes Exercise of 1.98M Warrants, Raising $4.64M - intellectia.ai
Vivos Therapeutics, Inc. Closes Exercise of Warrants Raising Approximately $4.64 Million for Working Capital - Quiver Quantitative
Sleep apnea device maker Vivos raises $4.64M in repriced warrant deal - Stock Titan
Vivos Therapeutics Completes Warrant Inducement Financing Transaction - TipRanks
Vivos Therapeutics Signs Warrant Inducement Agreement With Institutional Investor - TradingView
Chipmakers Recap: What is the dividend yield of Vivos Therapeutics IncAnalyst Upgrade & Low Risk High Reward Ideas - baoquankhu1.vn
Vivos Therapeutics (NASDAQ:VVOS) and Akebia Therapeutics (NASDAQ:AKBA) Head to Head Contrast - Defense World
Vivos Announces Warrant Exercise Agreement - Dentistry Today
Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds - MSN
Vivos Therapeutics announces $4.64 million warrant exercise deal By Investing.com - Investing.com Nigeria
Vivos Therapeutics Secures Convertible Bridge Financing Facility - TipRanks
Vivos Therapeutics Signs Convertible Note Agreement With V-Co Investors 3 - TradingView
Vivos Therapeutics announces $4.64 million warrant exercise deal - Investing.com India
Vivos Therapeutics (VVOS) Exercises Warrants for $4.64M in Funding - Intellectia AI
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds - The Manila Times
Sleep apnea device maker Vivos secures $4.64M from warrant exercise - Stock Titan
Dividend Watch: Is The Oncology Institute Inc Equity Warrants ROE strong enoughWeekly Earnings Recap & Weekly Momentum Picks - baoquankhu1.vn
Aug Summary: Is Vivos Therapeutics Inc part of any ETF2025 EndofYear Setup & Real-Time Volume Spike Alerts - baoquankhu1.vn
Vivos Therapeutics Inc Azioni (VVOS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.61%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):